Sonim Technologies regains Nasdaq minimum bid price compliance

DNA X, Inc.

Nasdaq notified Sonim on August 2, 2024, that its closing bid price was $1.00 or greater from July 18 to August 1, 2024.
Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and the matter is closed.
The notification resolves previous deficiency regarding minimum bid price requirement.

item 8.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-24-030182
form_type: 8-K
ticker: SONM
cik: 0001178697
company_name: DNA X, Inc.
filed_at: 2024-08-05T23:59:59+00:00
discovered_at: 2026-05-14T18:03:12.353170+00:00
generated_at: 2026-05-31T12:59:03.339619+00:00
sec_items: ["8.01"]
event_type: regulatory
sentiment: neutral
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-24-030182
json_url: https://secwatch.observer/filing/0001493152-24-030182.json
markdown_url: https://secwatch.observer/filing/0001493152-24-030182.md
text_url: https://secwatch.observer/filing/0001493152-24-030182.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1178697/000149315224030182/0001493152-24-030182-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1178697/000149315224030182/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

CLIR

ClearSign Technologies suspends ATM prospectus supplement for $10.39 million common stock offering; no shares sold

ClearSign Technologies Corp May 28, 2026, 4:19 PM ET regulatory Items 8.01, 9.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

QNCX

Quince Therapeutics regains Nasdaq listing compliance via equity alternative

Quince Therapeutics, Inc. May 21, 2026, 5:06 PM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

AIRE

reAlpha regains Nasdaq minimum bid price compliance; matter closed

reAlpha Tech Corp. May 14, 2026, 4:20 PM ET regulatory Items 8.01, 9.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

MSS

Maison Solutions regains Nasdaq minimum bid price compliance; listing continues

Maison Solutions Inc. May 12, 2026, 1:22 PM ET regulatory Items 7.01, 8.01, 9.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

LESL

Leslie's regains Nasdaq compliance for minimum market value of publicly held shares

Leslie's, Inc. June 1, 2026, 4:28 PM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory

Filing page SEC filing

RICK

RCI Hospitality regains Nasdaq compliance after filing delayed Q1 10-Q

RCI HOSPITALITY HOLDINGS, INC. June 1, 2026, 3:08 PM ET regulatory Items 8.01, 9.01

same SEC item: 8.01 same event type: regulatory

Filing page SEC filing

OTLK

Outlook Therapeutics resubmits BLA for ONS-5010 to FDA; Class 1 review, PDUFA in 60 days

Outlook Therapeutics, Inc. June 1, 2026, 9:15 AM ET regulatory Items 8.01, 9.01

same SEC item: 8.01 same event type: regulatory

Filing page SEC filing

VYGR

FDA clears IND for VY1706, Voyager's tau-silencing gene therapy for Alzheimer's

Voyager Therapeutics, Inc. June 1, 2026, 8:00 AM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory

Filing page SEC filing

Source: SEC EDGAR

accession 0001493152-24-030182

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.